Ketuo Biotech announced that as of August 31, 2026, the company had repurchased a total of 4.7876 million shares through centralized bidding transactions, accounting for 1.8170% of the company's current total share capital. The highest transaction price was 15.54 yuan/share, the lowest transaction price was 13.208 yuan/share, and the total transaction amount was 69.9935 million yuan. The total repurchase capital is not less than 100 million yuan and no more than 150 million yuan. The upper limit of the repurchase price was adjusted to no more than 29.36 yuan/share due to the implementation of equity distribution in 2025. The repurchase period is 12 months from the date the board of directors deliberates and approves the repurchase plan. The repurchase of shares is intended to be used for equity incentives or employee stock ownership plans.

Ketuo Biotech announced that as of August 31, 2026, the company had repurchased a total of 4.7876 million shares through centralized bidding transactions, accounting for 1.8170% of the company's current total share capital. The highest transaction price was 15.54 yuan/share, the lowest transaction price was 13.208 yuan/share, and the total transaction amount was 69.9935 million yuan. The total repurchase capital is not less than 100 million yuan and no more than 150 million yuan. The upper limit of the repurchase price was adjusted to no more than 29.36 yuan/share due to the implementation of equity distribution in 2025. The repurchase period is 12 months from the date the board of directors deliberates and approves the repurchase plan. The repurchase of shares is intended to be used for equity incentives or employee stock ownership plans.